Literature DB >> 18040654

Hypoxia and chronic lung disease.

Rubin M Tuder1, Jeong H Yun, Anil Bhunia, Iwona Fijalkowska.   

Abstract

The lung is both the conduit for oxygen uptake and is also affected by hypoxia and hypoxia signaling. Decreased ventilatory drive, airway obstructive processes, intra-alveolar exudates, septal thickening by edema, inflammation, fibrosis, or damage to alveolar capillaries will all interpose a significant and potentially life-threatening barrier to proper oxygenation, therefore enhancing the alveolar/arterial pO2 gradient. These processes result in decreased blood and tissue oxygenation. This review addresses the relationship of hypoxia with lung development and with lung diseases. We particularly focus on molecular mechanisms underlying hypoxia-driven physiological and pathophysiological lung processes, specifically in the infant lung, pulmonary hypertension, and chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040654     DOI: 10.1007/s00109-007-0280-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  59 in total

1.  Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

Authors:  N F Voelkel; R M Tuder
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  State of the Art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease.

Authors:  Eric A Hoffman; Brett A Simon; Geoffrey McLennan
Journal:  Proc Am Thorac Soc       Date:  2006-08

3.  Hypoxic lung whiteout: further clearing but more questions from on high.

Authors:  Erik R Swenson
Journal:  Ann Intern Med       Date:  2006-10-03       Impact factor: 25.391

4.  Improved lung growth and function through hypoxia-inducible factor in primate chronic lung disease of prematurity.

Authors:  Tiina M Asikainen; Ling-Yi Chang; Jacqueline J Coalson; Barbara K Schneider; Nahid S Waleh; Machiko Ikegami; John M Shannon; Vicki T Winter; Peter Grubb; Ronald I Clyman; Bradley A Yoder; James D Crapo; Carl W White
Journal:  FASEB J       Date:  2006-06-28       Impact factor: 5.191

Review 5.  Hypoxia- and non-hypoxia-related pulmonary hypertension - established and new therapies.

Authors:  Hossein A Ghofrani; Robert Voswinckel; Frank Reichenberger; Norbert Weissmann; Ralph T Schermuly; Werner Seeger; Friedrich Grimminger
Journal:  Cardiovasc Res       Date:  2006-08-01       Impact factor: 10.787

Review 6.  A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes.

Authors:  O A Kent; J T Mendell
Journal:  Oncogene       Date:  2006-10-09       Impact factor: 9.867

7.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

Authors:  M Sean McMurtry; Stephen L Archer; Dario C Altieri; Sebastien Bonnet; Alois Haromy; Gwyneth Harry; Sandra Bonnet; Lakshmi Puttagunta; Evangelos D Michelakis
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

8.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung.

Authors:  M Jakkula; T D Le Cras; S Gebb; K P Hirth; R M Tuder; N F Voelkel; S H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-09       Impact factor: 5.464

9.  Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.

Authors:  R M Tuder; M Chacon; L Alger; J Wang; L Taraseviciene-Stewart; Y Kasahara; C D Cool; A E Bishop; M Geraci; G L Semenza; M Yacoub; J M Polak; N F Voelkel
Journal:  J Pathol       Date:  2001-10       Impact factor: 7.996

10.  Diversity in mitochondrial function explains differences in vascular oxygen sensing.

Authors:  Evangelos D Michelakis; Vaclav Hampl; Ali Nsair; XiCheng Wu; Gwyneth Harry; Al Haromy; Rachita Gurtu; Stephen L Archer
Journal:  Circ Res       Date:  2002-06-28       Impact factor: 17.367

View more
  59 in total

Review 1.  Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease.

Authors:  Nels Olson; Albert van der Vliet
Journal:  Nitric Oxide       Date:  2011-01-01       Impact factor: 4.427

2.  Metabolism and Redox in Pulmonary Vascular Physiology and Pathophysiology.

Authors:  Norah Alruwaili; Sharath Kandhi; Dong Sun; Michael S Wolin
Journal:  Antioxid Redox Signal       Date:  2018-12-21       Impact factor: 8.401

3.  Beneficial Role of Erythrocyte Adenosine A2B Receptor-Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia.

Authors:  Hong Liu; Yujin Zhang; Hongyu Wu; Angelo D'Alessandro; Gennady G Yegutkin; Anren Song; Kaiqi Sun; Jessica Li; Ning-Yuan Cheng; Aji Huang; Yuan Edward Wen; Ting Ting Weng; Fayong Luo; Travis Nemkov; Hong Sun; Rodney E Kellems; Harry Karmouty-Quintana; Kirk C Hansen; Bihong Zhao; Andrew W Subudhi; Sonja Jameson-Van Houten; Colleen G Julian; Andrew T Lovering; Holger K Eltzschig; Michael R Blackburn; Robert C Roach; Yang Xia
Journal:  Circulation       Date:  2016-08-02       Impact factor: 29.690

4.  Numerical simulation of blood flow and pressure drop in the pulmonary arterial and venous circulation.

Authors:  M Umar Qureshi; Gareth D A Vaughan; Christopher Sainsbury; Martin Johnson; Charles S Peskin; Mette S Olufsen; N A Hill
Journal:  Biomech Model Mechanobiol       Date:  2014-03-09

Review 5.  Emerging role of angiogenesis in adaptive and maladaptive right ventricular remodeling in pulmonary hypertension.

Authors:  Andrea L Frump; Sébastien Bonnet; Vinicio A de Jesus Perez; Tim Lahm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-11-02       Impact factor: 5.464

6.  Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension.

Authors:  Yinzhong Zhang; Arunabh Talwar; Donna Tsang; Annette Bruchfeld; Ali Sadoughi; Maowen Hu; Kennedy Omonuwa; Kai Fan Cheng; Yousef Al-Abed; Edmund J Miller
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 7.  Emerging concepts in the pathogenesis of lung fibrosis.

Authors:  William D Hardie; Stephan W Glasser; James S Hagood
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

8.  Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall.

Authors:  Maria G Frid; Min Li; Meena Gnanasekharan; Danielle L Burke; Miguel Fragoso; Derek Strassheim; Joanna L Sylman; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-09-18       Impact factor: 5.464

9.  Rarefaction and blood pressure in systemic and pulmonary arteries.

Authors:  Mette S Olufsen; N A Hill; Gareth D A Vaughan; Christopher Sainsbury; Martin Johnson
Journal:  J Fluid Mech       Date:  2012-07-02       Impact factor: 3.627

Review 10.  Molecular mechanisms of hypoxia-inducible factor-induced pulmonary arterial smooth muscle cell alterations in pulmonary hypertension.

Authors:  Christine Veith; Ralph T Schermuly; Ralf P Brandes; Norbert Weissmann
Journal:  J Physiol       Date:  2015-09-30       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.